154 related articles for article (PubMed ID: 7143714)
1. [General pharmacology of T-1982, a new cephamycin antibiotic].
Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Arai H; Omori M; Tanada K; Senda N; Hashiba K; Matsukura K; Takata K; Okami H
Jpn J Antibiot; 1982 Sep; 35(9):2139-54. PubMed ID: 7143714
[TBL] [Abstract][Full Text] [Related]
2. [General pharmacology of T-2588, a new oral cephem antibiotic].
Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
[TBL] [Abstract][Full Text] [Related]
3. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
4. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
[TBL] [Abstract][Full Text] [Related]
5. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
[TBL] [Abstract][Full Text] [Related]
6. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological properties of the main metabolite of flosequinan.
Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
[TBL] [Abstract][Full Text] [Related]
8. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
10. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
11. [General pharmacological studies on isepamicin sulfate (HAPA-B)].
Shibata K; Mita I; Shinoda Y; Nakano U; Kinoshita H; Noguchi M; Uzawa T; Sohmiya Y; Takayanagi N
Jpn J Antibiot; 1987 Jan; 40(1):145-69. PubMed ID: 3586327
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties.
Kito G; Morimoto S; Shiomi M
Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346
[TBL] [Abstract][Full Text] [Related]
13. [General pharmacology of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic].
Tone H; Kiyosaki T; Nishimori T; Kobayashi F; Nishimura K; Morino H; Tsuchiyama M
Jpn J Antibiot; 1986 Feb; 39(2):526-46. PubMed ID: 3712756
[TBL] [Abstract][Full Text] [Related]
14. [General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)].
Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N; Omori M; Muroda T; Nakajima S; Nakada Y; Tanada K; Senda N; Tanaka K; Makino H
Jpn J Antibiot; 1980 Oct; 33(10):994-1018. PubMed ID: 6451724
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
16. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
17. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
[TBL] [Abstract][Full Text] [Related]
18. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological studies on new cephamycin, MT-141. (1) Its effect on central nervous system, respiration and cardiovascular system].
Kurebe M; Asaoka H; Yamaki Y; Sugiyama S; Shibasaki Y; Nishimori T; Kobayashi F
Jpn J Antibiot; 1984 Jul; 37(7):1428-39. PubMed ID: 6436555
[TBL] [Abstract][Full Text] [Related]
20. General pharmacology of the new quinolone antibacterial agent levofloxacin.
Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
